FDA Lacks Comprehensive Data to Determine Whether Risk Evaluation and Mitigation Strategies Improve Drug Safety.
Author:   Office of the Investigator General
Publisher:   Createspace Independent Publishing Platform
ISBN:  

9781722230739


Pages:   40
Publication Date:   05 July 2018
Format:   Paperback
Availability:   Available To Order   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Our Price $42.21 Quantity:  
Add to Cart

Share |

FDA Lacks Comprehensive Data to Determine Whether Risk Evaluation and Mitigation Strategies Improve Drug Safety.


Overview

FDA lacks comprehensive data to determine whether risk evaluation and mitigation strategies improve drug safety.

Full Product Details

Author:   Office of the Investigator General
Publisher:   Createspace Independent Publishing Platform
Imprint:   Createspace Independent Publishing Platform
Dimensions:   Width: 21.60cm , Height: 0.20cm , Length: 27.90cm
Weight:   0.118kg
ISBN:  

9781722230739


ISBN 10:   1722230738
Pages:   40
Publication Date:   05 July 2018
Audience:   General/trade ,  General
Format:   Paperback
Publisher's Status:   Active
Availability:   Available To Order   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Table of Contents

Reviews

Author Information

Tab Content 6

Author Website:  

Countries Available

All regions
Latest Reading Guide

April RG 26_2

 

Shopping Cart
Your cart is empty
 Shopping cart
Mailing List

 

Sign up now